This webinar provides a high-level overview of the new In-vitro Diagnostics EU Regulation (IVDR) that came into effect as of May 26th, 2022, and the implications for institutions offering laboratory-developed tests (LDTs).
In this session, we will focus on the impact for your laboratory, and provide some practical guidance to help with a smooth transition to digital pathology. From pragmatic considerations, when selecting a scanner, to workflow implications, this webinar aims to arm you with the information needed to identify the right solution.
Pathologist – Seattle Cancer Care Alliance, Assistant Professor – University of Washington, Dept. of Pathology
In this session, we will briefly review the basics of molecular biology, examine critical factors which affect the quality of nucleic acids in the tissues and cells which are submitted for downstream molecular diagnostics, and briefly introduce some...
M. Div., HT(ASCP), Director of Education & Training, Lab Management Consultants
In this age of healthcare regulatory standards and compliance, every aspect in diagnostic patient care must be developed, documented, and validated ‘before’ they can be used in testing and diagnoses. Procedures which were once deemed as ‘routine’, as in the...
Want us to feature your writing?
We are looking for more great writers to feature here. Send us a submission and we’ll be in touch!